Horowitz J D, Lang W J, Howes L G, Fennessy M R, Christophidis N, Rand M J, Louis W J
Lancet. 1980 Jan 12;1(8159):60-1. doi: 10.1016/s0140-6736(80)90490-0.
The acute effects of a single capsule of each of two phenylpropanolamine-containing preparations were determined in a group of healthy young adults, by means of a double-blind comparison with matching placebo preparations. Supine diastolic blood-pressure rose to 100 mm Hg or more in 12 out of 37 subjects taking an anorectic preparation ('Trimolets'; 85 mg phenylpropanolamine per capsule) and in 4 out of 34 subjects taking a decongestant preparation ('Contac 500'; 50 mg phenylpropanolamine per capsule). 20 of the subjects taking trimolets reported adverse side effects. The frequency and extent of the hypertensive response to high-dose phenylpropranolamine-containing preparations suggest that clinical use of such preparations should be reviewed and that their availability without prescription may not be appropriate.
通过与匹配的安慰剂制剂进行双盲比较,在一组健康的年轻成年人中测定了两种含苯丙醇胺制剂各一粒胶囊的急性效应。服用一种食欲抑制剂制剂(“Trimolets”;每粒胶囊含85毫克苯丙醇胺)的37名受试者中,有12人仰卧位舒张压升至100毫米汞柱或更高;服用一种减充血剂制剂(“Contac 500”;每粒胶囊含50毫克苯丙醇胺)的34名受试者中,有4人出现这种情况。服用Trimolets的受试者中有20人报告了不良副作用。对高剂量含苯丙醇胺制剂的高血压反应的频率和程度表明,应重新审视此类制剂的临床应用,且无处方可得可能并不合适。